Saúde
MATD3 — HOSPITAL MATER DEI S.A.
CNPJ 16.676.520/0001-59 · listed classes: MATD3 · CVM code 25690
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE ⟶ | 27.8%! | 15.2%! | 6.4% | 7.3% | -21.8% | 7.6% |
| ROIC ⟶ | 35.5%! | 18.5% | 11.0% | 11.0% | -9.0%! | 10.6% |
| ROA ⟶ | 6.1%! | 5.6%! | 2.7% | 2.8% | -6.8% | 2.6% |
| Gross margin ⟶ | 40.4% | 39.5% | 35.3% | 32.5% | 30.1% | 29.9% |
| EBIT margin ⟶ | 16.3% | 23.7% | 19.2% | 19.4% | -15.1% | 16.3% |
| Net margin ⟶ | 10.1% | 14.3% | 7.0% | 6.5% | -14.6% | 5.1% |
| Revenue growth (1y) ⟶ | — | 42.7%! | 72.1% | 24.1% | 1.8% | -2.3% |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 24.8%! |
| Net debt/EBITDA ⟶ | -0.18x | -0.59x | 1.93x | 1.78x | — | 1.67x |
| Current ratio ⟶ | 1.30x | 5.05x | 2.62x | 2.59x | 3.16x | 3.04x |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1 | 582.8 | 46.0 | 7.9% | 16.9 | 1.36 | 2024-05-07 |
| 2024T2! | 585.3 | -458.5 | -78.3% | -5.2 | 1.10 | 2024-08-15 |
| 2024T3! | 570.8 | 80.5 | 14.1% | -4.6 | 0.88 | 2024-12-25 |
| 2025T1! | 499.3 | 20.2 | 4.0% | -4.3 | 1.06 | 2025-05-08 |
| 2025T2 | 545.8 | 27.1 | 5.0% | 12.1 | 1.08 | 2025-08-13 |
| 2025T3 | 567.9 | 27.5 | 4.8% | 17.8 | 0.99 | 2025-11-09 |
| 2026T1 | 575.0 | 32.6 | 5.7% | 15.3 | 1.27 | 2026-05-06 |
| 2026T2 | 613.6 | 45.0 | 7.3% | 10.7 | 1.02 | 2026-08-12 |
Full series, every quarter: GET /empresas/MATD3/trimestres
Dividends per year
| year | per share | payments |
|---|---|---|
| 2025 | R$ 0.2254 | 2 |
| 2024 | R$ 0.0749 | 1 |
| 2023 | R$ 0.0643 | 1 |
| 2022 | R$ 0.0900 | 1 |
Piotroski F-Score 6/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2023 | DMPL 5.04 | -16.7 | -64.1 |
| 2023 | DMPL 5.05 | 54.4 | 101.7 |
| 2020 | DRE 3.02 | -427.8 | -455.7 |
| 2020 | DRE 3.03 | 290.1 | 262.2 |
This company appears in
Other companies in Healthcare
15 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/MATD3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 1,346 sessions, 2021-04-16 → 2026-09-04 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:36 UTC. If this does not match /saude, you are reading a cached copy.